Paul A. Friedman, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 48,920 shares at $511.98 ($25.6M) on 2026-01-09, disclosed to the SEC on 2026-01-13.
Open-market sale of $25.6M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $511.98 | 1,480 | $758K | 3.0% |
| 2 | $511.98 | 1,480 | $758K | 3.0% |
| 3 | $513.11 | 1,094 | $561K | 2.2% |
| 4 | $513.11 | 1,094 | $561K | 2.2% |
| 5 | $514.68 | 1,345 | $692K | 2.7% |
| 6 | $514.68 | 1,345 |
| $692K |
| 2.7% |
| 7 | $515.81 | 1,996 | $1.0M | 4.0% |
| 8 | $515.81 | 1,996 | $1.0M | 4.0% |
| 9 | $516.84 | 766 | $396K | 1.5% |
| 10 | $516.84 | 766 | $396K | 1.5% |
| 11 | $517.86 | 2,450 | $1.3M | 5.0% |
| 12 | $517.86 | 2,450 | $1.3M | 5.0% |
| 13 | $518.68 | 1,363 | $707K | 2.8% |
| 14 | $518.68 | 1,363 | $707K | 2.8% |
| 15 | $519.88 | 846 | $440K | 1.7% |
| 16 | $519.88 | 846 | $440K | 1.7% |
| 17 | $521.03 | 681 | $355K | 1.4% |
| 18 | $521.03 | 681 | $355K | 1.4% |
| 19 | $521.98 | 840 | $438K | 1.7% |
| 20 | $521.98 | 840 | $438K | 1.7% |
| 21 | $523.00 | 970 | $507K | 2.0% |
| 22 | $523.00 | 970 | $507K | 2.0% |
| 23 | $524.10 | 1,199 | $628K | 2.5% |
| 24 | $524.10 | 1,199 | $628K | 2.5% |
| 25 | $525.05 | 2,432 | $1.3M | 5.0% |
| 26 | $525.05 | 2,432 | $1.3M | 5.0% |
| 27 | $526.00 | 1,066 | $561K | 2.2% |
| 28 | $526.00 | 1,066 | $561K | 2.2% |
| 29 | $526.97 | 1,560 | $822K | 3.2% |
| 30 | $526.97 | 1,560 | $822K | 3.2% |
| 31 | $528.18 | 575 | $304K | 1.2% |
| 32 | $528.18 | 575 | $304K | 1.2% |
| 33 | $529.17 | 691 | $366K | 1.4% |
| 34 | $529.17 | 691 | $366K | 1.4% |
| 35 | $529.76 | 166 | $88K | 0.3% |
| 36 | $529.76 | 166 | $88K | 0.3% |
| 37 | $530.69 | 280 | $149K | 0.6% |
| 38 | $530.69 | 280 | $149K | 0.6% |
| 39 | $532.50 | 80 | $43K | 0.2% |
| 40 | $534.16 | 332 | $177K | 0.7% |
| 41 | $534.16 | 332 | $177K | 0.7% |
| 42 | $535.29 | 148 | $79K | 0.3% |
| 43 | $535.29 | 148 | $79K | 0.3% |
| 44 | $536.02 | 473 | $254K | 1.0% |
| 45 | $536.02 | 473 | $254K | 1.0% |
| 46 | $536.88 | 487 | $261K | 1.0% |
| 47 | $536.88 | 487 | $261K | 1.0% |
| 48 | $537.85 | 80 | $43K | 0.2% |
| 49 | $537.85 | 80 | $43K | 0.2% |
| 50 | $539.23 | 480 | $259K | 1.0% |
| 51 | $539.23 | 480 | $259K | 1.0% |
| 52 | $540.36 | 600 | $324K | 1.3% |
| 53 | $540.36 | 600 | $324K | 1.3% |
| 54 | $545.79 | 40 | $22K | 0.1% |
| Total | $522.35 avg | 48,920 | $25.6M | 100% |
| Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |
| MDGL | SELL | 2025-07-22 | $980K | — | Filing → |